Stroke Center
Save the date1st Erasmus MC conference on Acute Stroke TreatmentMarch 24 and 25, 2017Rotterdam, The Netherlands
For the latest updates visit www.erasmusmc-acute-stroke-conference.nl
a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a
a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a
Program
1st Erasmus MC conference on Acute Stroke Treatment
Friday, March 24, 2017 a Update IAT Trialsa Selection for IATa Improving IAT procedurea Intracerebral hemorrhage
Saturday, March 25, 2017 a Translational science in acute strokea Future of acute stroke treatment
Masterclassesa CT/CTA analysis in acute strokea Getting the best out of your data
In our new approach we link presentations of renowned speakers to presentations of junior researchers to encourage scientific discussion.
SUBMIT YOUR ABSTRACT NOW! Deadline: December 31, 2016
Friday, March 24, 2017 A. Session: Update IAT Trials
09.00 – 09.30h MR CLEAN and beyond (research and clinic) Diederik Dippel, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
09.30 – 10.00h Evidence from data pooling projects: opportunities and limitations Mayank Goyal, Departments of Clinical Neuroscience and Radiology, Hotchkiss Brain Institute, Cummings School of Medicine, University of Calgary, Calgary, AB, Canada
10.00 – 10.10h Scientific presentation (abstract) 10.10 – 10.20h Scientific presentation (abstract) 10.20 – 10.30h Scientific presentation (abstract) 10.30 – 11.00h Break B. Session: Selection for IAT
11.00 – 11.30h Will image based selection ever reach the clinical arena? Charles Majoie, Academic Medical Center, Amsterdam, The Netherlands
11.30 – 12.00h Prediction rules. Theory and Application Hester Lingsma, Department of Public Health, Centre for Medical Decision Making, Erasmus MC, Rotterdam, The Netherlands
12.00 – 12.10h Scientific presentation (abstract) 12.10 – 12.20h Scientific presentation (abstract) 12.20 – 12.30h Scientific presentation (abstract) 12.30 – 14.00h LUNCH
POSTER PRESENTATIONS C. Session: Improving IAT procedure
14.00 – 14.20h Devices. Has the optimal device already been developed? Petr Widimsky, Cardiocenter, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
14.20 – 14.40h Why do we not know which co-medication is best for our patients? Heinrich Mattle, Department of Neurology, University Hospital Bern, Inselspital, Switzerland
14.40 – 15.00h Access, balloons and distal access. Technical challenges in IAT; what is the current evidence? Geert Lycklama a Nijeholt, Deptartment of Radiology, HMC, The Hague, The Netherlands
15.00 – 15.10h Scientific presentation (abstract)
15.10 – 15.20h Scientific presentation (abstract) 15.30 – 15.30h Scientific presentation (abstract) 15.30 – 16.00h Break
Program
D. Session: Intracerebral hemorrhage
16.00 – 16.30h Diagnostic work up and selection for treatment Karin Klijn, Department of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands
16.30 – 17.00h Minimal invasive surgery: techniques, indications and outcome Jan Regelsberger, Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
17.00 – 17.10h Scientific presentation (abstract) 17.10 – 17.20h Scientific presentation (abstract) 17.20 – 17.30h Scientific presentation (abstract)
Saturday, March 25, 2017 E. Session: Translational science in acute stroke
09.00 – 09.30h The role of thrombus and coagulation Simon de Meyer, KU Leuven Kulak, Kortrijk, Belgium
09.30 – 10.00h Ischemic cascade, inflammatory response and impaired microvascular perfusion Denis Vivien, Clinical Research Department, Medical Center, Caen University Hospital, Caen, France
10.00 – 10.10h Scientific presentation (abstract) 10.10 – 10.20h Scientific presentation (abstract) 10.20 – 10.30h Scientific presentation (abstract) 10.30 – 11.00h Break F. Session: Future of acute stroke treatment
11.00 – 11.10h Scientific presentation (abstract) 11.10 – 11.20h Scientific presentation (abstract) 11.20 – 11.30h Scientific presentation (abstract) 11.30 – 11.50h Ongoing trials update 2016-2020
Keith Muir, Institute of Neuroscience and Psychology, University of Glasgow, Glasgow, UK
11.50 – 12.10h Guideline development Wim van Zwam, Maastricht University Medical Center, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands
12.10 – 12.30h A perspective on future stroke treatment Tudor Jovin, University of Pittsburgh Medical Center Stroke Institute, Presbyterian University Hospital, Pittsburgh, PA, USA End of program at congress center
G. Masterclasses (at Erasmus MC)
14.00 – 16.30h CT/CTA analysis in acute stroke, an interactive workshop
Bart Emmer, neuro-interventionalist in one of the MR Clean study centers (Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands) and Aad van der Lugt, one of the MR CLEAN PIs will give a concise overview of all relevant imaging biomarkers in acute stroke treatment (Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands)
14.00 – 16.30h Getting the best out of your data: basic and advanced clinical stroke study design and analysis
Hester Lingsma, methodological expert and trial statistician of the MR CLEAN trial (Erasmus MC, University Medical Center Rotterdam,Rotterdam, The Netherlands) and Diederik Dippel, one of the MR CLEAN PIs ((Erasmus MC, University Medical Center Rotterdam,Rotterdam, The Netherlands) will discuss with you the many approaches and pitfalls to stroke trial design and analysis.
